Optimal thromboprophylaxis following bioprosthetic aortic valve replacement: still a matter of debate?
Open Access
- 5 April 2012
- journal article
- review article
- Published by Oxford University Press (OUP) in Interactive CardioVascular and Thoracic Surgery
- Vol. 15 (1) , 109-114
Abstract
Optimal thromboprophylaxis following bioprosthetic aortic valve replacement (AVR) remains controversial. The main objective, which is the effective prevention of central nervous or peripheral embolic events, especially in the early postoperative period, will have to be weighed against the haemorrhagic risk that is associated with the utilization of different antithrombotic regimes. Most governing bodies in cardiovascular medicine have issued recommendations on thromboprophylaxis after the surgical implantation of aortic bioprostheses. However, the level of evidence to support these recommendations remains low, largely due to the inherent limitations of conducting appropriately randomized and adequately powered clinical research in this area. It is apparent from the recent surveys and large registries that there is a great variability in antithrombotic practice at an institutional or individual-clinician level reflecting this controversy and the lack of robust evidence. While organizational, financial or conceptual limitations could hinder the conduct and availability of conclusive research on optimal thromboprophylaxis after aortic bioprosthesis, it is imperative that all evidence is presented in a systematic way in order to assist the decision-making for the modern clinician. In this review, we provide an outline of the current recommendations for thromboprophylaxis, followed by a comprehensive and analytical presentation of all comparative studies examining anticoagulation vs. antiplatelet therapy after bioprosthetic AVR.Keywords
This publication has 25 references indexed in Scilit:
- Newly Identified Events in the RE-LY TrialNew England Journal of Medicine, 2010
- Anticoagulation after bioprosthetic aortic valve replacementThe Journal of Thoracic and Cardiovascular Surgery, 2010
- Choice of Prosthetic Heart Valve in AdultsJACC, 2010
- Is early antithrombotic therapy necessary in patients with bioprosthetic aortic valves in normal sinus rhythm?The Journal of Thoracic and Cardiovascular Surgery, 2010
- Guideline on antiplatelet and anticoagulation management in cardiac surgeryEuropean Journal of Cardio-Thoracic Surgery, 2008
- Antithrombotic therapy after bioprosthetic aortic valve replacement: ACTION Registry survey results☆European Journal of Cardio-Thoracic Surgery, 2008
- Antiplatelet therapy early after bioprosthetic aortic valve replacement is unnecessary in patients without thromboembolic risk factorsEuropean Journal of Cardio-Thoracic Surgery, 2007
- Valvar heart disease and prosthetic heart valvesBMJ, 2002
- Aortic Bioprosthesis Without Early Anticoagulation-Risk of ThromboembolismThe Thoracic and Cardiovascular Surgeon, 1995
- Risk of thromboembolism with the aortic Carpentier-Edwards bioprosthesisThe Annals of Thoracic Surgery, 1995